Webinar – “Latest advances in the treatment of acute myeloid leukemia (AML) – What does this mean for patients?” – video recording
On 21 March 2023, CLLAN (CLL Advocates Network) collaborated in the joint initiative with ALAN (Acute Leukemia Advocates Network), CMLAN (CML Advocates Network) and UK charity organisation Leukaemia Care, and hosted the first webinar in the series of four.
This webinar brought together international patients with AML, patient advocates and stakeholders from different countries around the globe. The aim of this educational webinar was to give patients and advocates an overview of how AML is treated today and the significance of ’hot topics’ and key treatment development advances published and discussed at 2022 international haematology conferences EHA22 and ASH22. What is new and what does this mean for patients?
We were joined by:
Charlotte Martin – Patient Advocacy Manager, Leukaemia Care (UK)
Dr Mike Dennis – Consultant Hematologist, The Christie NHS Foundation Trust (UK)
Anne -Pierre Pickaert – Patient Advocate, Acute Leukemia Advocates Network (FR)
A big thank you to all patient and advocates who were able to attend live, and to our panellists for their excellent presentation, insight and for sharing their wealth of experience.
We would like to thank the following for their support: